Table 1.
Clinical and epidemiological characteristics of the eight patients included in the study with adverse events following YFV-17D vaccination
Case no.Auto-Abs to type I IFNsInborn errors of type I IFNsaCountry of origin and residenceSexAge (yr)Family historyYFV-17D diseaseVaccination year and ageClinical and biological featuresYFV-17D isolateOther severe infectious diseases and age (yr)Co-morbidities (age of diagnosis)Patient
1 Negative AR IFNAR1 deficiency Brazil 16 — YEL-AVD 2017, 12 yr Fever, shock, renal and hepatic insufficiency, pleural effusion and atelectasis Blood No None P2, Hernandez et al., 2019  
2 Negative AR IFNAR2 deficiency Brazil 35 Sister died from YEL-AVD at 19 yr YEL-AVD 1999, 13 yr Fever, hypotension, bleeding, hepatitis, thrombopenia Not tested No None P1, this report 
3 Positive Negative Germany 62 — YEL-AND/YEL-AVD 2016, 57 yr Fever, meningo-encephalitis, hepatitis Urine Influenza B pneumonia, 59 yr None P2, this report 
4 Positive Negative Brazil 50 — YEL-AVD 2017, 47 yr Fever, shock, renal insufficiency, hepatic insufficiency, thrombopenia Blood No SLE (47 yr) P3, this report 
5 Positive Negative US 80 — YEL-AVD 2004, 64 yr Fever, shock, renal insufficiency, thrombopenia, hepatitis Blood No None P4, this report 
6 Negative Negative Brazil 25 2 siblings (brother, aged 32 yr and sister, aged 32 yr) died from YEL-AVD YEL-AVD 2018, 28 yr Fever, nausea, vomiting, headache, hepatitis Blood No None — 
7 Negative Negative Brazil 25 Father: myasthenia gravis YEL-AND 2017, 22 yr Fever, headache, vomiting, dizziness CSF No None — 
8 Negative Negative Belgium 56 YEL-AND 2020, 56 yr Fever, headache, cognitive problems CSF No None — 
Case no.Auto-Abs to type I IFNsInborn errors of type I IFNsaCountry of origin and residenceSexAge (yr)Family historyYFV-17D diseaseVaccination year and ageClinical and biological featuresYFV-17D isolateOther severe infectious diseases and age (yr)Co-morbidities (age of diagnosis)Patient
1 Negative AR IFNAR1 deficiency Brazil 16 — YEL-AVD 2017, 12 yr Fever, shock, renal and hepatic insufficiency, pleural effusion and atelectasis Blood No None P2, Hernandez et al., 2019  
2 Negative AR IFNAR2 deficiency Brazil 35 Sister died from YEL-AVD at 19 yr YEL-AVD 1999, 13 yr Fever, hypotension, bleeding, hepatitis, thrombopenia Not tested No None P1, this report 
3 Positive Negative Germany 62 — YEL-AND/YEL-AVD 2016, 57 yr Fever, meningo-encephalitis, hepatitis Urine Influenza B pneumonia, 59 yr None P2, this report 
4 Positive Negative Brazil 50 — YEL-AVD 2017, 47 yr Fever, shock, renal insufficiency, hepatic insufficiency, thrombopenia Blood No SLE (47 yr) P3, this report 
5 Positive Negative US 80 — YEL-AVD 2004, 64 yr Fever, shock, renal insufficiency, thrombopenia, hepatitis Blood No None P4, this report 
6 Negative Negative Brazil 25 2 siblings (brother, aged 32 yr and sister, aged 32 yr) died from YEL-AVD YEL-AVD 2018, 28 yr Fever, nausea, vomiting, headache, hepatitis Blood No None — 
7 Negative Negative Brazil 25 Father: myasthenia gravis YEL-AND 2017, 22 yr Fever, headache, vomiting, dizziness CSF No None — 
8 Negative Negative Belgium 56 YEL-AND 2020, 56 yr Fever, headache, cognitive problems CSF No None — 

F, female; M, male.

a

Coding regions of IFNAR1, IFNAR2, TYK2, JAK1, STAT1, STAT2, and IRF9.

or Create an Account

Close Modal
Close Modal